Fundraising Fox

Ngm Biopharmaceuticals

South San Francisco, US · Delaware corporation · 3 known investors

Biotech

Founders & leadership

MT
McHenry T. Tichenor, Jr.Director
WJ
William J. RieflinExecutive Officer, Director
PS
Peter SvennilsonDirector
JC
Jin-Long ChenExecutive Officer, Director
ML
Mark LeschlyDirector
DV
David V. GoeddelDirector
DS
David SchnellDirector

Investors · 3

Foresite CapitalLarkspur
Prospect Venture PartnersMenlo Park · $3M – $5M
The Column GroupreportedSan Francisco · $30Mvia Peter Svennilson · board

Reported raises · per SEC filings

Form D private placements
▶$106MraisedMar 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark LeschlyDirector
  • Peter SvennilsonDirector
  • David SchnellDirector
  • David V. GoeddelDirector
  • Jin-Long ChenExecutive Officer, Director
  • William J. RieflinExecutive Officer, Director
  • McHenry T. Tichenor, Jr.Director
Offering amount
$106M
Amount sold
$106M
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.7MraisedFeb 2015 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • McHenry T. Tichenor, Jr.Director
  • William J. RieflinExecutive Officer, Director
  • Peter SvennilsonDirector
  • Jin-Long ChenExecutive Officer, Director
  • Mark LeschlyDirector
  • David V. GoeddelDirector
  • David SchnellDirector
Offering amount
$60M
Amount sold
$20.7M
First sale
Oct 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.